European Union -
Norwegian -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Norway -
Norwegian -
Statens legemiddelverk
bugnanto 5 mikrog/ time
sandoz - københavn - buprenorfin - depotplaster - 5 mikrog/ time
Norway -
Norwegian -
Statens legemiddelverk
bugnanto 10 mikrog/ time
sandoz - københavn - buprenorfin - depotplaster - 10 mikrog/ time
Norway -
Norwegian -
Statens legemiddelverk
bugnanto 20 mikrog/ time
sandoz - københavn - buprenorfin - depotplaster - 20 mikrog/ time
Norway -
Norwegian -
Statens legemiddelverk
bugnanto 30 mikrog/ time
sandoz - københavn - buprenorfin - depotplaster - 30 mikrog/ time